Here are some more anecdotal results:
In Marseille the IHU-Méditerrannée Infection, the institute where dr Raoult is employed, has up until midday 11 April treated 2401 cases of COVID19 with the HCQ/AZ combination with 10 fatalities (0.4%). In the state and university hospitals in Marseille not affiliated with this institute 4100 cases have been treated with 63 deaths (1.5%).
It should be noted that both results so far are good.
Obviously factors such as age, comorbidities, other medication etc must be taken into account when comparing the two populations, however just making an initial comparison between the rough numbers tells us that the likelihood of such a difference occurring by chance alone is less than 0.0002 (ie 2 chances in 10 000).
Again, calculating from the rough numbers alone, dr Raoult's institute ought to have seen 37 fatalities. Thus, 27 people were saved by treating 2401 patients to a cost in medication per saved patient of less than $1800.
Now, we know from the latest publication by dr Raoult that he certainly did also treat the elderly and patients with other illnesses. So, what is going on here - and why are the leading medical authorities so negative?
PS Yes, chloroquine and hydroxychloroquine have side effects, and some are serious. However, in almost all cases I've been able to find they have either been described in conjunction with malaria treatment where the acute dosage is many times what has been proposed for the COVID19 patients, or they have occurred only after many years during chronic treatment (RA, lupus) with doses more reminicient of what is given to the COVID19-patients for a few days up to a week.
Thanks ScaniaBoy.